These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 29672896)

  • 21. Hepatitis C: a new direction, but an old story?
    Gluud C; Koretz R; Gurusamy K
    Lancet; 2014 Jun; 383(9935):2122-3. PubMed ID: 24953469
    [No Abstract]   [Full Text] [Related]  

  • 22. 'Real-life' experience with direct-acting antiviral agents for hepatitis C virus in end-stage renal disease.
    García-Agudo R; Aoufi-Rabih S; Salgueira-Lazo M; González-Corvillo C; Fabrizi F
    Int J Artif Organs; 2018 Jul; 41(7):363-370. PubMed ID: 29582685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. What are the management issues for hepatitis C in dialysis patients?: natural history of hepatitis C in dialysis populations.
    Carrion AF; Martin P
    Semin Dial; 2014; 27(5):446-8. PubMed ID: 25204876
    [No Abstract]   [Full Text] [Related]  

  • 24. Treatment of HCV infected patients and renal disease.
    Kershenobich D
    Ann Hepatol; 2010; 9 Suppl():103-6. PubMed ID: 20714005
    [TBL] [Abstract][Full Text] [Related]  

  • 25. What are the management issues for hepatitis C in dialysis patients?: epidemiology and prevention of hepatitis C virus transmission in the hemodialysis setting.
    Jadoul M; Fabrizi F
    Semin Dial; 2014; 27(5):449-51. PubMed ID: 25204877
    [No Abstract]   [Full Text] [Related]  

  • 26. CDC and USPSTF 2012 recommendations for screening for hepatitis C virus infection: overview and take-home messages.
    Kanwal F; Lok AS; El-Serag HB
    Gastroenterology; 2013 Mar; 144(3):478-81. PubMed ID: 23419454
    [No Abstract]   [Full Text] [Related]  

  • 27. When and how can nephrologists treat hepatitis C virus infection in dialysis patients?
    Davis MI; Chute DF; Chung RT; Sise ME
    Semin Dial; 2018 Jan; 31(1):26-36. PubMed ID: 28925068
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chronic viral hepatitis and kidney failure].
    Chaabane NB; Loghmari H; Melki W; Hellara O; Safer L; Bdioui F; Saffar H
    Presse Med; 2008 Apr; 37(4 Pt 2):665-78. PubMed ID: 18291615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-alpha therapy within the first year after acute hepatitis C infection in hemodialysis patients: efficacy and tolerance.
    Rocha CM; Perez RM; Narciso JL; Ferreira AP; Lemos LB; Medina-Pestana JO; Silva AE; Ferraz ML
    Eur J Gastroenterol Hepatol; 2007 Feb; 19(2):119-23. PubMed ID: 17272996
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hepatitis C in potential kidney and heart transplant patients.
    Fabrizi F; Bunnapradist S; Martin P
    Clin Liver Dis; 2005 Aug; 9(3):487-503, viii. PubMed ID: 16023979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Universal Disease Screening and Treatment - The Egyptian Example.
    Haseltine WA
    N Engl J Med; 2020 Mar; 382(12):1081-1083. PubMed ID: 32187465
    [No Abstract]   [Full Text] [Related]  

  • 32. Hepatitis C-Positive Kidney Transplant Recipients-When Is The Best Time to Treat With Direct-Acting Antiviral Agents?
    Singh N; Dies D; Samant H
    Transplantation; 2017 May; 101(5):e192. PubMed ID: 28437390
    [No Abstract]   [Full Text] [Related]  

  • 33. A new direction for hepatitis C.
    The Lancet
    Lancet; 2014 Apr; 383(9925):1270. PubMed ID: 24725562
    [No Abstract]   [Full Text] [Related]  

  • 34. Management of chronic hepatitis C: consensus guidelines.
    Sherman M; Shafran S; Burak K; Doucette K; Wong W; Girgrah N; Yoshida E; Renner E; Wong P; Deschênes M
    Can J Gastroenterol; 2007 Jun; 21 Suppl C(Suppl C):25C-34C. PubMed ID: 17568824
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Eliminating HCV: a marathon, not a sprint.
    The Lancet Gastroenterology Hepatology
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):515. PubMed ID: 32416859
    [No Abstract]   [Full Text] [Related]  

  • 36. [Prevention and treatment of viral hepatitis in renal insufficiency conditions].
    Fontaine H; Pol S
    Nephrologie; 2001; 22(7):339-47. PubMed ID: 11817211
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Summaries for patients. Hepatitis C Virus testing of persons born during 1945-1965: recommendations from the Centers for Disease Control and Prevention.
    Ann Intern Med; 2012 Dec; 157(11):I-38. PubMed ID: 23346582
    [No Abstract]   [Full Text] [Related]  

  • 38. Screening blood-borne virus among incarcerated inmates.
    Chong VH
    Int J STD AIDS; 2008 Nov; 19(11):795. PubMed ID: 18931282
    [No Abstract]   [Full Text] [Related]  

  • 39. Treatment of hepatitis C in hemodialysis patients with pegylated interferon alpha-2a as monotherapy.
    Sikole A; Dzekova P; Selja N; Gaseva M; Nikolov IG; Zabzun M; Muharemi S; Asani A; Amitov V; Mena S; Grunevska V; Ivanovski L; Polenakovic M
    Ren Fail; 2007; 29(8):961-6. PubMed ID: 18067041
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Viral hepatitis in patients on chronic hemodialysis and staff members in hemodialysis centers].
    Furuta S; Oguchi H
    Nihon Rinsho; 1992 Jan; 50 Suppl():751-6. PubMed ID: 1578761
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.